Cimivir L

Product Description

Indication:

Treating chronic hepatitis C virus (HCV) infection in certain patients.

Ledipasvir & Sofosbuvir is a combination of 2 hepatitis C virus (HCV) antiviral agents. It reduces the amount of HCV in the body by preventing the spread of the HCV within the body.

Dosage and Administration:

Ledipasvir & Sofosbuvir (90 mg/400 mg) is a fixed-dose combination tablet . The recommended dosage is one tablet once daily, with or without food.

Precaution:

• Tell your doctor or dentist that you take Ledipasvir & Sofosbuvir  before you receive any medical or dental care, emergency care, or surgery.
• Do not share needles, injection supplies, or items like toothbrushes or razors. Talk with your health care provider about ways to prevent the spread of HCV to others.